Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by Spartrapon Sep 15, 2020 8:54am

116 Views

Post# 31558855

RE:RE:RE:Shorts?

Anyway, whatever is the normal explanation for this phenomenon, it's been growing since mid august, so I think it means something peculiar

Last 5 days short percent	82.45%
Last 10 days short percent	80.72%
Last 20 days short percent	71.62%
Last 50 days short percent	58.08%

SABBOBCAT wrote: I haven't looked, but it would be worthwhile to aggregate the information from the TSX and NASDAQ. It may be that traders are able to sell into the US and cover at a slightly lower price in Canada.

Bullboard Posts

Eminent acquires promising Nevada gold project